4-TERT-BUTYLCALIX[4]ARENE-TETRAACETIC ACID TETRAETHYL ESTER:Exports & Compliance White Paper 2026

I. Executive Summary

4-tert-Butylcalix[4]arene-tetraacetic acid tetraethyl ester (CAS 97600-39-0) is a lower-rim-functionalised calix[4]arene: four para-tert-butylphenol units joined by methylene bridges into a macrocyclic cavity, with all four phenolic oxygens alkylated by ethoxycarbonylmethoxy groups. The molecular formula is C60H80O12 with a molecular weight near 993.3 g/mol. This white paper is written from a CDMO perspective for B2B buyers. The compound has no approved therapeutic indication, it is supplied as Research Use Only material for supramolecular chemistry, separation science, sensing and materials research, and it is not a finished consumer product.

Three characteristics shape every commercial discussion. The molecule is conformationally non-trivial: calix[4]arenes adopt cone, partial cone, 1,2-alternate and 1,3-alternate arrangements, and only the right one has the cavity geometry a buyer needs, so conformational identity is part of the specification rather than a footnote. It is a tetra-substitution product, so partial substitution and residual phenolic sites are the characteristic impurities. And it is expensive to make and purify at scale, which puts unit value high and lot sizes small.

Buyers therefore purchase characterisation as much as material. A defensible lot file combines a 1H and 13C NMR conformational fingerprint, mass-spectrometric confirmation of the intact macrocycle, evidence of complete tetra-alkylation, residual-alkylating-agent control, residual-solvent and metal-ion data, and a clear statement of solid form and purity basis. Suppliers who offer that package as standard compete on reproducibility; those who offer a purity percentage compete on price and lose the technical evaluation.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

The calix[4]arene framework is a pre-organised host. Four phenolic rings held in a cyclic array create a cavity whose size and donor arrangement are set by conformation, while the appended ester groups supply the ligating donors. Host behaviour follows from that architecture, and so do the analytical methods needed to prove it.

• Conformational Stereochemistry: Rotation of the phenolic units through the macrocyclic annulus is hindered, giving four discrete conformers: cone, partial cone, 1,2-alternate and 1,3-alternate. Alkylation of the lower rim with bulky substituents generally locks the cone, which presents all four ethoxycarbonylmethoxy donors on the same face and defines the cavity. The cone is readily identified by a pair of AB doublets for the bridging methylene protons with a large geminal coupling and by the characteristic upfield methylene carbon resonance associated with adjacent aromatic rings in a syn arrangement.
• Host-Guest Behaviour and Lipophilicity: The tetra-ester is the lipophilic, organic-soluble form of a family whose hydrolysed tetra-acid analogue is used in cation extraction work; the ester is valued where solubility in organic media, processability into membranes or incorporation into polymer matrices is required. Complexation is governed by cavity size, donor pre-organisation and the templating cation present during synthesis, which is why residual alkali-metal content is a quality attribute rather than an incidental impurity.

2.2 Synthesis and Manufacturing Technologies

Manufacturing proceeds in two stages, described here at the level of route class and control strategy; conditions, stoichiometries and scale-up parameters belong inside a qualified facility under a campaign-specific risk assessment. Both stages are classical, but both create impurities that dominate the specification and the cost.

• Base-Catalysed Phenol-Formaldehyde Cyclisation: The macrocycle is built by base-catalysed condensation of para-tert-butylphenol with formaldehyde, a cyclisation whose outcome depends on base, cation template and thermal profile, and which yields the cyclic tetramer alongside linear oligomers and resinous by-products. Controls centre on oligomer and resin removal, on complete removal of unreacted phenol and formaldehyde, and on isolating the cyclic tetramer in the conformational form required.
• Tetra-Alkylation and Purification Strategy: Lower-rim functionalisation with an ethyl haloacetate under basic conditions installs four ethoxycarbonylmethoxy groups. The defining quality issue is completeness: tri- and di-substituted species, residual phenolic OH and residual alkylating agent must all be controlled, and the alkylating agent warrants genotoxic-impurity treatment under ICH M7 logic. Purification relies on column chromatography and recrystallisation, both solvent-intensive, which is the principal reason throughput is poor and unit cost is high at larger scale.

2.3 Core Application Matrix

• Ion Extraction and Separation Research: Functionalised calixarenes are studied as selective extractants for alkali, alkaline-earth, lanthanide and actinide cations in hydrometallurgical and nuclear-effluent treatment research, and as components of supported liquid membranes and extraction chromatographic materials. The tetra-ester is used where organic-phase solubility and membrane compatibility are required; it is a research material, not a deployed treatment product.
• Sensing and Supramolecular Materials: The pre-organised cavity with appended donors makes the scaffold a platform for ion-selective electrodes, optical and electrochemical sensors, host-guest supramolecular assemblies and functional polymers. Researchers typically require documented conformational identity, because sensor response depends directly on which conformer is present.
• Custom Analogue and Reference Programmes: The compound is frequently bought alongside the corresponding tetra-acid and mixed-ester analogues as a characterised set for comparative studies, and as a starting material for further derivatisation under a confidentiality agreement with a single custom-synthesis partner.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Demand is academic and industrial-research driven, tracking funded programmes in separation science, sensing and supramolecular materials rather than any commercial product cycle. It is therefore low-volume, high-value and irregular. A visible shift is that buyers now specify conformation and substitution completeness explicitly, having learned that lots nominally sold under the same name can behave differently in extraction or sensing experiments.

3.2 Capacity Distribution and Export Flows

Capacity is small and specialist. There is no commodity production; campaigns run in kilo-lab and small pilot equipment at fine-chemical and custom-synthesis sites able to handle large-volume chromatography and crystallisation. Chinese and Indian sites increasingly provide synthesis capacity, while European, North American and Japanese specialists contribute analytical characterisation, catalogue supply, small-lot repackaging and distribution. Export flows follow that division, with bulk campaign material moving from Asia to Western distributors and to end users.

3.3 Market Bifurcation and Pricing Dynamics

Pricing reflects purification effort far more than raw materials. RUO-grade material at a stated purity with basic NMR and mass confirmation is quoted per gram at a premium that already accounts for chromatography yield loss. Development-grade or project material, with a full conformational fingerprint, impurity profile, residual-alkylating-agent and metal data, documented solid form and change control, is quoted as a campaign with milestone payments and lead times driven by chromatographic throughput. Volume discounts exist but are limited, because doubling a batch roughly doubles solvent and silica consumption.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

As a research macrocycle with no approved therapeutic indication, the compound carries the compliance profile of an industrial research chemical: inventory status, hazard communication and the buyer's end-use obligations, reinforced by the quality expectations of the institutions that purchase it.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

• REACH Registration Position: Manufacture or import into the EU at or above one tonne per year requires a full registration dossier. Calixarene volumes sit far below that, so the practical issue is confirming whether the substance is registered or covered as a non-phase-in material, and establishing who bears any enquiry or registration duty before contracting. Buyers should obtain that statement in writing, since institutional procurement increasingly requires it.
• CLP, SDS and RUO Communication: Classification, labelling and packaging under CLP with an SDS in the destination language are required, and the SDS drives packaging group, transport declaration and workplace controls including HBEL-based OEB banding where a classification applies. Documentation should also carry an explicit Research Use Only statement and a not-for-human-or-veterinary-use declaration, because the material must not be represented as a therapeutic or consumer product.

4.2 North American Market: TSCA, EPA, and FDA Regulations

• TSCA Inventory and Reporting Basis: Commercial import into the United States requires the substance to be on the TSCA inventory or covered by an applicable exemption such as the research-and-development exemption, a low-volume exemption or a PMN route. Suppliers should state the basis on the import documentation and confirm who bears reporting duties, because research-quantity imports are routinely handled under the R&D exemption with a certification statement.
• Non-API Status and End-Use Screening: The compound is not an FDA-approved active ingredient, holds no DMF or CEP, and is not a listed food-contact or cosmetic ingredient. Certificates should state Research Use Only, and the buyer's declared end use should be screened under Know-Your-Customer, particularly for enquiries that suggest extraction or separation work with regulated radionuclide or defence-adjacent applications.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

Macrocycle purification is among the most solvent-intensive work in fine chemicals, which makes environmental performance a genuine differentiator rather than a formality.

5.1 Carbon Footprint and Circular Economy

Chromatography dominates the footprint: silica production and disposal, large eluent volumes and their distillation or incineration, plus energy for concentration and drying. Credible mitigation includes replacing at least part of the chromatographic step with crystallisation or selective precipitation, recovering eluent with a documented recycling rate, substituting less hazardous solvent systems where resolution permits, and reducing silica consumption through higher loading. Buyers increasingly request Scope 1 and 2 site figures plus Scope 3 transport estimates, and ISO 14001 certification with a documented solvent and solid-waste route is a common requirement.

5.2 Sustainable Sourcing and Traceability

Traceability should name the manufacturing site, the cyclisation and alkylation route classes, the origin of the phenol and formaldehyde inputs, and the chromatographic and crystallisation history of the lot. Because the material is bought for reproducible research, batch genealogy and a reserved-sample policy are what allow a buyer to compare results across campaigns. End-use declarations, Know-Your-Customer screening and a stated SVHC position complete a defensible package, and ISO 9001 certification with documented change control is the framework that makes it auditable.

VI. Supply Chain Resilience and Export Logistics

The finished macrocycle is a stable, high-melting solid, so logistics risk is low compared with the supply risk of long chromatographic lead times and small campaign sizes.

6.1 Packaging Standards and Moisture/Contamination Control

• Clean, Low-Particulate Primary Packaging: Supply in amber glass or lined containers with heat-induction seals and a secondary barrier, packed to minimise static and particulate contamination. Because lots are small and valuable, sub-lotting under controlled conditions with retained samples is standard practice, and each sub-lot should carry the parent batch reference.
• Solvent Residue and Solid-Form Stability: Calixarenes readily retain included solvent, so packaging should follow confirmation of residual-solvent levels rather than a fixed drying schedule, and the certificate should state the solid form and any solvate propensity observed. Desiccation and protection from strong light are prudent for long storage, with a stated retest interval.

6.2 Dangerous Goods Identification and Transit Protocols

Classification must be derived from the SDS and lot-specific data; high-molecular-weight macrocyclic solids are frequently non-hazardous for transport, but residual solvent content can change that determination and affect packing group and documentation under ADR, IMDG and IATA DGR. Air freight is normal for gram-to-hundred-gram orders, with sea freight for consolidated campaigns. Because unit values are high, shippers should use tracked, insured services and customs descriptions that name the CAS and state Research Use Only, which reduces both clearance delay and misclassification risk.

VII. Enterprise Global Expansion Strategy Guide

Three moves determine success in the macrocycle segment.

1. Make Conformation a Specification Line: Offer the NMR conformational fingerprint, mass confirmation and substitution-completeness data as standard deliverables. In this field the customer's experiment fails if the conformer is wrong, so characterisation is the product.
2. Invest in Non-Chromatographic Purification: Process development that converts part of the purification burden into crystallisation or selective precipitation lowers cost, raises throughput and improves the environmental profile simultaneously, and is the clearest route to a durable margin.
3. Sell Programmes, Not Bottles: Offer the ester alongside the acid and mixed analogues as a characterised set under one confidentiality agreement, with tech-transfer discipline, reserved samples and change-control notification, which is what institutional buyers actually need for reproducible work.

VIII. Conclusion

4-tert-Butylcalix[4]arene-tetraacetic acid tetraethyl ester is a specialist host molecule with no approved therapeutic indication, supplied Research Use Only and valued for what its cavity does in extraction, sensing and materials research. Its commercial logic follows from its chemistry: conformational identity, substitution completeness and chromatographic purification cost define both quality and price, and small-lot, high-unit-value supply is structural rather than incidental. Suppliers who treat characterisation and purification development as their core competence build durable positions in a market that is too small for commodity competition.

For buyers, the discipline is to specify the conformer and the impurity story before ordering, and to qualify the supplier's analytical practice rather than its price list. Require the conformational fingerprint, mass confirmation, residual-alkylating-agent and metal data, residual-solvent results and a solid-form statement, and confirm reserved-sample and change-control commitments. In macrocycle sourcing, reproducibility is the attribute worth paying for, and it is bought with specification rather than with discount.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global 4-TERT-BUTYLCALIX[4]ARENE-TETRAACETIC ACID TETRAETHYL ESTER Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global 4-TERT-BUTYLCALIX[4]ARENE-TETRAACETIC ACID TETRAETHYL ESTER supply chain:

• China Custom Macrocycle Ecosystem: Custom-synthesis specialists in Shanghai, Jiangsu, Shandong and Zhejiang run cyclisation and alkylation campaigns with access to large-volume chromatography and crystallisation, at competitive conversion cost and with flexible scheduling. Diligence should focus on conformational analysis capability, substitution-completeness evidence and English-language certificates, since those are what determine whether a lot performs in the buyer's experiment.
• European Specialist Macrocycle Ecosystem: German, British, Italian and Czech suppliers and research-chemical houses provide small lots with full NMR and mass-spectrometric characterisation, RUO documentation, REACH and CLP compliance and ISO 9001 quality systems. Unit prices are higher, but the documentation, reserved-sample discipline and reliable desiccated logistics are what institutional buyers are purchasing.
• North American and Japanese Research-Grade Ecosystem: Catalogue and custom suppliers in the United States and Japan serve supramolecular and separation-science groups with characterised macrocycles, analogue sets and strong analytical support, often tied to academic collaborations. Lead times are short for catalogue items and long for custom analogues, and the premium reflects analytical depth and reproducibility.